Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1180 of 5804
-
Could 5 radiation sessions be as good as 30 for skin cancer?
Disease control Recruiting nowThe purpose of this study is to compare the effectiveness and side effects of stereotactic radiotherapy (5 sessions) against conventional (standard) radiotherapy (20-30 sessions) for the treatment of skin cancer involving the head and neck after surgical resection. Stereotactic …
Phase: NA • Sponsor: David Palma • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New pill targets tough cancers with genetic flaw
Disease control Recruiting nowSolid tumours are abnormal lumps of tissue that can occur in different parts of the body. The tumours involved in this study have specific genetic characteristics that can make them more aggressive and challenging to treat. The study will test whether GSK5460025 alone or in combi…
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can a weekly pill and weight lifting rebuild aging bones?
Disease control Recruiting nowThe aim of the present clinical trial is to examine the effects of everolimus, resistance training, or their combination on bone and muscle health formation in elderly women aged 60-75 years. The main questions it aims to answer are: Can rapamycin's analog (Everolimus), resistan…
Phase: PHASE2 • Sponsor: Odense University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New hope for teens with rare bleeding disorder: experimental drug enters final testing
Disease control Recruiting nowThe main purpose of this study is to confirm the correct dose of efgartigimod IV for treating patients aged 12 to younger than 18 years with chronic immune thrombocytopenia (ITP). The study consists of a double-blinded treatment period (DBTP) in which the participants will be ra…
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New shot aims to boost immunity against HPV in HIV patients
Disease control Not yet recruitingThis study is testing the immunotherapeutic agent, PDS0101, in adults living with HIV who are also infected with human papillomavirus (HPV) type 16. The purpose of the study is to learn whether PDS0101 is safe and whether it can help the body's immune system respond to HPV 16. Re…
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New drug targets mysterious chronic itch
Symptom relief Recruiting nowThe primary objective of this study is to assess the PK/PD relationship of nemolizumab in adult participants aged 18 years or above with chronic pruritus of unknown origin (CPUO) during a 16-week treatment period.
Phase: PHASE2 • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New balloon could offer alternative for clogged heart stents
Disease control Recruiting nowA prospective, multi-center, single-blind, randomized (1:1), non-inferiority study comparing clinical outcomes of the Virtue® Sirolimus AngioInfusion™ Balloon (SAB) to the AGENT™ Paclitaxel Drug-Coated Balloon (DCB) in the treatment of coronary artery in-stent restenosis (ISR).…
Phase: NA • Sponsor: Orchestra BioMed, Inc • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New program aims to boost HIV prevention in ugandan teens with education, peer support, and savings accounts
Prevention Recruiting nowThe study will employ a multilevel combination intervention focused on PrEP initiation and adherence among adolescent girls and young women (AGYW) (aged 15-24) living in HIV hotpots in Uganda. Specifically, the study will combine: 1) HIV risk reduction (HIVRR) that incorporates s…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 07:56 UTC
-
New drug cocktail aims to shrink Hard-to-Treat cancers
Disease control Recruiting nowAn open-label, multicenter, phase II clinical study to evaluate the efficacy and safety of LBL-024 in combination with other drugs for the treatment of patients with advanced solid tumour.
Phase: PHASE2 • Sponsor: Nanjing Leads Biolabs Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could changing the order of two cancer drugs boost their power?
Disease control Recruiting nowThis research plan involves a treatment approach for advanced hepatocellular carcinoma (HCC) in the context of metabolic-associated steatotic liver disease (MASLD). The study aims to compare the efficacy differences between sequential therapy and concurrent therapy using bevacizu…
Phase: PHASE2, PHASE3 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could a single injection replace biopsies for breast cancer?
Diagnosis ENROLLING_BY_INVITATIONThe study should evaluate the \[99mTc\]Tc -ZHER2:4107 accumulation in primary tumour of breast cancer patients with different HER2 expression
Phase: PHASE2 • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
New stent technique aims to stop deadly bleeding without harming the brain
Disease control Recruiting nowTransjugular intrahepatic portosystemic shunt (TIPS) is a key therapeutic intervention for complications of portal hypertension. However, the risk of post-procedural hepatic encephalopathy (HE) limits its broader clinical application. In the management of gastroesophageal varicea…
Phase: NA • Sponsor: Air Force Military Medical University, China • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Blood marker may help doctors spot and treat respiratory failure before it worsens
Disease control Recruiting nowAcute hypoxemic respiratory failure (AHRF) happens when the lungs are unable to absorb enough oxygen. The bloodstream is deprived of oxygen which can eventually lead to more severe conditions like multi-organ failure (MOF) and death. AHRF accounts for over 30% of patients to crit…
Phase: PHASE2 • Sponsor: Lorenzo delSorbo • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for genital eczema: drug trial targets severe itch and pain
Disease control Recruiting nowHypothesis: Treatment with tralokinumab in patients with moderate-to-severe AD involving the genital region is expected to lead to significant improvements in PROs and clinical disease severity. These improvements will be assessed using genital-specific scoring systems, validated…
Sponsor: University Hospital Schleswig-Holstein • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a High-Fat diet tame Super-Refractory seizures?
Disease control Recruiting nowThe purpose of the study is to investigate to evaluate the efficacy and safety of ketogenic diet (KD) as an adjunctive therapy in patients with Super Refractory Status Epilepticus (SRSE) in the intensive care unit (ICU).
Phase: NA • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New combo therapy aims to shield kidneys in IgA disease
Disease control Recruiting nowThis multicenter, open-label, prospective single-arm study will enroll adults (≥18 y) with primary IgA nephropathy confirmed by renal biopsy within 2 weeks, eGFR ≥20 ml/min/1.73 m² and 0.5-3.5 g/d proteinuria, to receive early (real-world) combination therapy with RASI (titrated …
Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New PET tracer aims to spot hidden cancers
Diagnosis Recruiting nowGlutamine is a crucial nutrient for cancer cell growth, and its metabolism is frequently dysregulated in malignancies. 18F-FGln is a PET tracer that targets this altered glutamine metabolism. However, there are currently limited studies on the diagnostic value of 18F-FGln PET/CT …
Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
Bile duct cancer surgery showdown: total removal may lower recurrence risk
Disease control Recruiting nowWhen lymph node dissection of stations 12 and 13 is performed, resecting the bile duct from the superior portion of the pancreas to the confluence of the right and left hepatic ducts allows complete removal of the station 12 and 13 lymph nodes. Preserving the bile duct from the s…
Phase: NA • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New combo therapy aims to ease fibromyalgia pain
Symptom relief Recruiting nowFibromyalgia (FM) is a chronic pain syndrome characterized by widespread pain, fatigue, and emotional disorders. Its onset is related to factors such as central sensitization and imbalance of neurotransmitters. The current mainstream treatments include pregabalin, but the efficac…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Immunotherapy-Chemo cocktail shows promise for Hard-to-Treat bile duct cancer
Disease control Recruiting nowThe purpose of this clinical trial is to evaluate the safety and effectiveness of a new combination therapy for patients with biliary tract cancer that cannot be removed by surgery. Participants will receive an immunotherapy drug called adebrelimab combined with two chemotherapy …
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC